Patent · US Active

Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies

US10513560B2 · kind B2 · utility

1Cited by

29References

21Claims

0Family size

Assignees

CSL Behring AG · DE
CSL LIMITED · AU

Inventors

Con Panousis · Melbourne, AU
Veronika Rayzman · Melbourne, AU
Andrew Donald Nash · Melbourne, AU
Michael Wilson · Colchester, GB
Stefan Schmidbauer · Lahntal, DE
Marc Nolte · Marburg, DE

Key dates

Filing date	Nov 27, 2017
Grant date	Dec 24, 2019
Priority date	—
Expiry date	Jun 6, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.